Dynamic evaluation by TV-pupillometry of the mydriatic effect of ibopamine solution. Controlled studies

G. Micieli, C. Tassorelli, R. Iannacchero, E. Lodola, P. Barbieri, G. Nappi

Research output: Contribution to journalArticle

Abstract

The aim of the study was to evaluate in man the dose-effect relationship of ibopamine solution 0.25%, 0.50%, and 1% on the pupillary diameter and the pupillary reflex to light stimulus and near vision. A cross-over study was performed in comparison with a placebo and with tropicamide solution 1% in 18 healthy volunteers. The results show that ibopamine 1% determines a marked mydriatic effect. At the doses used, it produces maximum increase of the pupillary diameter with a dose-effect relationship which does not depart significantly from a straight line. The maximum mydriatic effect of ibopamine 1% is significantly greater than that of tropicamide 1%. The mydriatic effect of ibopamine lasts for about 3 h; that of tropicamide lasts longer. Tropicamide 1% markedly and for a long period inhibits the pupillary reflex both to light and to near vision. The effect of ibopamine 1% on the pupillary reflext to near vision is slight, while on the reflex to light stimulus it is essentially comparable to that of tropicamide.

Original languageEnglish
Pages (from-to)150-156
Number of pages7
JournalArzneimittel-Forschung/Drug Research
Volume40
Issue number2
Publication statusPublished - 1990

Fingerprint

Tropicamide
Mydriatics
Pupillary Reflex
Light
Cross-Over Studies
Reflex
Healthy Volunteers
Placebos
ibopamine

Keywords

  • Dopaminergic drugs
  • Ibopamine, clinical studies
  • Mydriatics
  • Ophthalmics
  • Tropicamide, clinical studies

ASJC Scopus subject areas

  • Chemistry(all)
  • Organic Chemistry
  • Drug Discovery
  • Pharmacology

Cite this

Dynamic evaluation by TV-pupillometry of the mydriatic effect of ibopamine solution. Controlled studies. / Micieli, G.; Tassorelli, C.; Iannacchero, R.; Lodola, E.; Barbieri, P.; Nappi, G.

In: Arzneimittel-Forschung/Drug Research, Vol. 40, No. 2, 1990, p. 150-156.

Research output: Contribution to journalArticle

@article{a7f336708fd042348d16bc2ed876ec69,
title = "Dynamic evaluation by TV-pupillometry of the mydriatic effect of ibopamine solution. Controlled studies",
abstract = "The aim of the study was to evaluate in man the dose-effect relationship of ibopamine solution 0.25{\%}, 0.50{\%}, and 1{\%} on the pupillary diameter and the pupillary reflex to light stimulus and near vision. A cross-over study was performed in comparison with a placebo and with tropicamide solution 1{\%} in 18 healthy volunteers. The results show that ibopamine 1{\%} determines a marked mydriatic effect. At the doses used, it produces maximum increase of the pupillary diameter with a dose-effect relationship which does not depart significantly from a straight line. The maximum mydriatic effect of ibopamine 1{\%} is significantly greater than that of tropicamide 1{\%}. The mydriatic effect of ibopamine lasts for about 3 h; that of tropicamide lasts longer. Tropicamide 1{\%} markedly and for a long period inhibits the pupillary reflex both to light and to near vision. The effect of ibopamine 1{\%} on the pupillary reflext to near vision is slight, while on the reflex to light stimulus it is essentially comparable to that of tropicamide.",
keywords = "Dopaminergic drugs, Ibopamine, clinical studies, Mydriatics, Ophthalmics, Tropicamide, clinical studies",
author = "G. Micieli and C. Tassorelli and R. Iannacchero and E. Lodola and P. Barbieri and G. Nappi",
year = "1990",
language = "English",
volume = "40",
pages = "150--156",
journal = "Arzneimittel-Forschung/Drug Research",
issn = "0004-4172",
publisher = "Editio Cantor Verlag GmbH",
number = "2",

}

TY - JOUR

T1 - Dynamic evaluation by TV-pupillometry of the mydriatic effect of ibopamine solution. Controlled studies

AU - Micieli, G.

AU - Tassorelli, C.

AU - Iannacchero, R.

AU - Lodola, E.

AU - Barbieri, P.

AU - Nappi, G.

PY - 1990

Y1 - 1990

N2 - The aim of the study was to evaluate in man the dose-effect relationship of ibopamine solution 0.25%, 0.50%, and 1% on the pupillary diameter and the pupillary reflex to light stimulus and near vision. A cross-over study was performed in comparison with a placebo and with tropicamide solution 1% in 18 healthy volunteers. The results show that ibopamine 1% determines a marked mydriatic effect. At the doses used, it produces maximum increase of the pupillary diameter with a dose-effect relationship which does not depart significantly from a straight line. The maximum mydriatic effect of ibopamine 1% is significantly greater than that of tropicamide 1%. The mydriatic effect of ibopamine lasts for about 3 h; that of tropicamide lasts longer. Tropicamide 1% markedly and for a long period inhibits the pupillary reflex both to light and to near vision. The effect of ibopamine 1% on the pupillary reflext to near vision is slight, while on the reflex to light stimulus it is essentially comparable to that of tropicamide.

AB - The aim of the study was to evaluate in man the dose-effect relationship of ibopamine solution 0.25%, 0.50%, and 1% on the pupillary diameter and the pupillary reflex to light stimulus and near vision. A cross-over study was performed in comparison with a placebo and with tropicamide solution 1% in 18 healthy volunteers. The results show that ibopamine 1% determines a marked mydriatic effect. At the doses used, it produces maximum increase of the pupillary diameter with a dose-effect relationship which does not depart significantly from a straight line. The maximum mydriatic effect of ibopamine 1% is significantly greater than that of tropicamide 1%. The mydriatic effect of ibopamine lasts for about 3 h; that of tropicamide lasts longer. Tropicamide 1% markedly and for a long period inhibits the pupillary reflex both to light and to near vision. The effect of ibopamine 1% on the pupillary reflext to near vision is slight, while on the reflex to light stimulus it is essentially comparable to that of tropicamide.

KW - Dopaminergic drugs

KW - Ibopamine, clinical studies

KW - Mydriatics

KW - Ophthalmics

KW - Tropicamide, clinical studies

UR - http://www.scopus.com/inward/record.url?scp=0025159386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025159386&partnerID=8YFLogxK

M3 - Article

C2 - 2334454

AN - SCOPUS:0025159386

VL - 40

SP - 150

EP - 156

JO - Arzneimittel-Forschung/Drug Research

JF - Arzneimittel-Forschung/Drug Research

SN - 0004-4172

IS - 2

ER -